-- Introduction
Dr. Balyeat
specializes
in the medical
and surgical
management
of diseases
affecting the
vitreous and
retina. This
includes the
management
of retinal
detachment,
retinal vascular
conditions
including diabetic
retinopathy
and retinal
vein occlusion,
age-related
macular degeneration
(AMD), inflammatory
eye disease
(“uveitis”),
and retinopathy
of prematurity
(ROP). Dr.
Balyeat also
performs vitreous
surgery using
small gauge “sutureless” systems
and performs
surgery with
implantation
of artificial
drainage devices
used to treat
a very severe
form of glaucoma, “neovascular” glaucoma.
His patients
therefore include
both the very
young and elderly.
-- Biography
Dr. Balyeat
is a graduate
of Duke University
and the University
of Oklahoma
College of
Medicine. He
completed his
residency in
ophthalmology
at the University
of Oklahoma’s
Dean A. McGee
Eye Institute
in Oklahoma
City, Oklahoma.
Dr. Balyeat
then completed
a fellowship
in vitreoretinal
surgery at
Piedmont Hospital
in Atlanta,
Georgia under
the direction
of Drs. William
S. Hagler and
William H.
Jarrett. He
is certified
by the American
Board of Ophthalmology
and is a fellow
of the American
Association
and the American
Society of
Retina Specialists
(formerly the
Vitreous Society).
He principally
practices at
St. John Medical
Center but
is also on
the medical
staffs of St.
Francis Hospital,
Hillcrest Medical
Center, and
SouthCrest
Hospital. Dr.
Balyeat began
his practice
at the Eye
Institute in
Tulsa in 1988.
-- Treatment
State-of-the-art
technology
assists Dr.
Balyeat in
treating his
patients’ medical
and surgical
eye problems
in a timely
fashion. Many
retinal detachments
are managed
in the office
using a technique
called pneumatic
retinopexy.
He has immediate
access to ocular
ultrasonography
with three-dimensional
capabilities,
an 810 nm wavelength
infrared laser
(with subthreshold
micropulse
photocoagulation
capability
for the treatment
of diabetic
retinopathy
without creating
visible laser
burns), and
a 689 nm wavelength
infrared laser
(“Opal
laser”)
for AMD patients
who may benefit
from photodynamic
therapy (PDT).
Dr. Balyeat
also uses intraocular
medications
for the management
of exudative
(“wet”)
AMD including
Lucentis, Avastin
and Macugen.
Dr. Balyeat
has high resolution
digital photographic
capabilities
and uses optical
coherence tomography
(OCT) to evaluate
patients with
diseases of
the macula
and optic nerve.
Clinical patient
data is managed
using an electronic
medical record
developed by
Dr. Balyeat.
Dr. Balyeat
invites you
to learn more
about his ophthalmology
practice and
diseases of
the vitreous
and retina
by visiting
his website:
www.balyeatretinasurgery.com
